Indian J Pharm Close
 

Figure 2: Effect of pharmacological interventions on myocardial infarct size. I R denotes ischemia reperfusion; IPC denotes ischemic preconditioning; HL denotes hyperlipidemia; Ins denotes insulin; Pio denotes pioglitazone; Wor denotes wortmannin; Rap denotes rapamycin. Values are expressed as mean ± standard deviation, a = P < 0.05 versus Sham Control and basal value; b = P < 0.05 versus ischemia-reperfusion control; c = P < 0.05 versus ischemic preconditioning control; d = P < 0.05 versus ischemic preconditioning + hyperlipidemia; e = P < 0.05 versus ischemic preconditioning + hyperlipidemia + Ins + Pio

Figure 2: Effect of pharmacological interventions on myocardial infarct size. I R denotes ischemia reperfusion; IPC denotes ischemic preconditioning; HL denotes hyperlipidemia; Ins denotes insulin; Pio denotes pioglitazone; Wor denotes wortmannin; Rap denotes rapamycin. Values are expressed as mean ± standard deviation, a = <i>P</i> < 0.05 versus Sham Control and basal value; b = <i>P</i> < 0.05 versus ischemia-reperfusion control; c = <i>P</i> < 0.05 versus ischemic preconditioning control; d = <i>P</i> < 0.05 versus ischemic preconditioning + hyperlipidemia; e = <i>P</i> < 0.05 versus ischemic preconditioning + hyperlipidemia + Ins + Pio